These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17095241)

  • 1. A primer on the mechanics of P-glycoprotein the multidrug transporter.
    Hennessy M; Spiers JP
    Pharmacol Res; 2007 Jan; 55(1):1-15. PubMed ID: 17095241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.
    Garrigues A; Escargueil AE; Orlowski S
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10347-52. PubMed ID: 12145328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P glycoprotein and the mechanism of multidrug resistance.
    Váradi A; Szakács G; Bakos E; Sarkadi B
    Novartis Found Symp; 2002; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
    Konings WN; Poelarends GJ
    IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R; Sharom FJ
    Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
    Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools.
    Sharom FJ; Liu R; Qu Q; Romsicki Y
    Semin Cell Dev Biol; 2001 Jun; 12(3):257-65. PubMed ID: 11428918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma.
    Zandvliet M; Teske E; Schrickx JA
    Toxicol In Vitro; 2014 Dec; 28(8):1498-506. PubMed ID: 24975508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains.
    Kwan T; Gros P
    Biochemistry; 1998 Mar; 37(10):3337-50. PubMed ID: 9521654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
    Liu R; Sharom FJ
    Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein: from genomics to mechanism.
    Ambudkar SV; Kimchi-Sarfaty C; Sauna ZE; Gottesman MM
    Oncogene; 2003 Oct; 22(47):7468-85. PubMed ID: 14576852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.
    Garrigues A; Nugier J; Orlowski S; Ezan E
    Anal Biochem; 2002 Jun; 305(1):106-14. PubMed ID: 12018951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic cycle of P-glycoprotein.
    Senior AE; al-Shawi MK; Urbatsch IL
    FEBS Lett; 1995 Dec; 377(3):285-9. PubMed ID: 8549739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance protein 1 is not associated to detergent-resistant membranes.
    Cerf E; Gasper R; Belani JD; Rychnovsky S; Chang XB; Buyse F; Ruysschaert JM
    Biochem Biophys Res Commun; 2007 Apr; 355(4):1025-30. PubMed ID: 17336270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advance in the mechanism study of polymeric inhibitors of P-glycoprotein].
    Huang LM; Zhao JH; Wang GC; Zhou JP
    Yao Xue Xue Bao; 2010 Oct; 45(10):1224-31. PubMed ID: 21348299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiologic function of P-glycoprotein].
    Pávek P; Fendrich Z; Staud F
    Cesk Fysiol; 2002 Aug; 51(3):99-107. PubMed ID: 12402786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.